Clinical Trials Browser

INDUSTRY × Etoposide × Thoracic × Clear all

Extensive Stage Small Cell Lung Cancer

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Bites and Stings, Lung Neoplasms

Recurrence, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Cancer Extensive Stage

Small Cell Lung Carcinoma

Lung Neoplasms, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

SCLC,Extensive Stage

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

Widespread Small Cell Lung Cancer

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Cancer Extensive Stage

Extensive Stage Small Cell Lung Cancer

Small Cell Lung Carcinoma

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Lung Neoplasms

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Lung Neoplasms, Pleural Effusion, Malignant, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

SCLC, Extensive Stage

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Clinical Trials

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

SEZanne

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

SYS6090 Combination Therapy in Advanced Lung Cancer

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

IMforte

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy

DeLLphi-312

MK-6070-003

SKYSCRAPER-02C

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

SKYSCRAPER-02

TROPION-Lung12

DAREONᵀᴹ-8

A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC

A Study of Ivonescimab in First-Line ES-SCLC

CASPIAN

A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

KEYVIBE-006

KEYNOTE-B99

Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer

MK 7339-013

LUMINANCE

IN10018 Combination Therapy in Treatment-naïve ES-SCLC

Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC

Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

ORCHARD

CLOVER

REPLATINUM

Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer

Trial of BMS-986012 in Combination With Platinum and Etoposide

A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer

SCLC

MAURIS

Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC

REPLATINUM

A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC

M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

IMpower133

A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

KEYNOTE-604

A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer

Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)